KFSHRC Revolutionizes Global Healthcare with AI and Robotics

King Faisal Specialist Hospital & Research Centre ( KFSHRC) is making a major progress into the use of artificial intelligence (AI) and robotics. KFSHRC is achieving more accurate diagnoses, faster patient care and better treatment outcomes. At the heart of this technological evolution is the Centre for Healthcare Intelligence (CHI).

It employs 20 AI applications to optimise medical image management, patient flows and resource management. This approach has enabled the development of a sustainable AI ecosystem, with the aim of perfecting personalised treatments.

KFSHRC is achieving more accurate diagnoses, faster patient care and better treatment outcomes CHI has implemented predictive models that identify high-risk patients early

These are patients who need bone marrow transplants or who could be readmitted for heart failure. This real-time prediction capability has significantly improved clinical decision-making. Additionally, in collaboration with the Saudi Commission for Health Specialties, the hospital has launched an applied AI training program for healthcare professionals, fostering more advanced leadership in the adoption of these technologies.

One of the KFSHRC’s greatest achievements has been in the area of ​​radiology. Here, AI tools have increased diagnostic accuracy by 25% and reduced misdiagnosis rates by 18%. This has been key in the early detection of cancer and cardiovascular diseases.

The Capacity Command Centre, also powered by AI, has proven essential in automating tasks and optimising resource allocation. It has enabled more efficient care. Since 2021, more than 170,000 interventions have been carried out, reducing the waiting time for beds from 32 hours to just 6 hours. In addition, 90% of pharmacy and laboratory services are now completed in less than 15 minutes.

The hospital continues to expand its technological capabilities with JuhAIna, a generative AI system designed to facilitate decisions regarding organ transplants. This advancement will be showcased at the upcoming Global Health Expo in Riyadh, highlighting the hospital’s commitment to adopting cutting-edge technologies.

90% of pharmacy and laboratory services are now completed in less than 15 minutes by KFSHRC

KFSHRC’s efforts in innovation and advanced healthcare have been recognized globally. The hospital has been included in the list of The World’s Best Smart Hospitals for 2025 by Newsweek.

Additionally, it has received the 2022 Leadership Award in Artificial Intelligence and the 2022 Zimam Digital Health Award. In terms of prestige, the hospital is ranked first in the Middle East and Africa and twentieth globally on the list of Top 250 Academic Medical Centers, for the second consecutive year. It has also been recognized as the most valuable healthcare brand in the Kingdom of Saudi Arabia and the entire region, according to Brand Finance’s 2024 rankings.

__

(Featured image by Igor Omilaev via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in iSanidad. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us